Printer Friendly
The Free Library
19,585,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bioscience Market Access Associates Teams with CEOs of Emerging Bioscience Companies to achieve Rapid Commercialization of New Technologies.


Business Editors

RALEIGH, N.C.--(BUSINESS WIRE)--July 31, 2003

Focus on Process and Execution Yields faster ROI (Return On Investment) The monetary benefits derived from having spent money on developing or revising a system. In the IT world, there are more ways to compute ROI than Carter has liver pills (and for those of you who never heard of that expression, it means a lot).  

Bioscience Market Access Associates (BMAA BMAA British Microlight Aircraft Association
BMAA Baptist Missionary Association of America
BMAA Beta-N-Methyl Amino-L-Alanine
) has crafted a formula that plays well with CEOs of emerging Bioscience companies as they commercialize new technologies. Along with offering strategic advice, BMAA goes further, formulating a tailored commercialization process with execution milestones that can become the backbone of the client's commercialization function.

"The old saying 'talk is cheap' doesn't apply here," said Don Van Dyke Van Dyke (or van/Van Dijk or Dyk etc) is a surname of Dutch origin. It refers to:
  • Sir Anthony van Dyck, (1599 – 1641), Flemish-born painter who lived in England
  • Barry Van Dyke (born 1951), American actor, son of Dick Van Dyke
, founder of BMAA. "In fact all talk and no action is a luxury emerging firms simply cannot afford. These companies need an action plan that produces results both immediately and in the long term."

Playing on the founder's 25 years of operating experience in Clinical Diagnostics, Genomics, Proteomics and Bioinformatics, BMAA has assembled resources in a wide range of disciplines to allow CEOs to get to market quickly. Core competencies BMAA brings in Strategic Marketing, Marketing Management, Sales Management Sales Management Role and Goal
Importance of sales management is critical for any commercial organization. Expanding business in not possible without increasing sales volumes, and effective sales management goal is to organize sales team work in such a manner that ensures a
 and International Business are augmented by external resources in Marketing Communications, Graphic Design, Field Sales, and Inside Sales.

Van Dyke began at American Hospital Supply in its diagnostic businesses as a sales rep and sales manager where he won achievement awards six years in a row. Later he joined venture-funded Bio Image Corporation as VP Sales. Bio Image was acquired first by Kodak then Millipore Corporation. Achievements such as assembling the first physical map of the human genome in 1992 were part of the ground breaking work Bio Image facilitated for researchers in Bioscience. In 1994 Van Dyke led a management buyout Management buyout (MBO)

Leveraged buyout whereby the acquiring group is led by the firm's management.


management buyout

See going private.
 of Bio Image from Millipore and, as CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , led the firm to profitability.

BMAA has provided consulting services to emerging companies including Bio Image (Ann Arbor, MI) BioSeq (Woburn, MA) Meridian Software (Raleigh, NC) Molecular Mining Corporation (Kingston, ON) Ribonomics (Durham, NC) Somalogic (Boulder, CO) and The Discovery Machine (Williamsport, PA.)

"The combination of our core competencies with external resources like PWB (Printed Wiring Board) An alternate term for printed circuit board. See printed circuit board.  Marketing Communications www.pwb.com and others can rapidly take a new technology into the competitive marketplace and start putting points on the scoreboard," Van Dyke continued, "all without investing in the time and expense of building the infrastructure from scratch."
COPYRIGHT 2003 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jul 31, 2003
Words:364
Previous Article:ADS Financial Services Solutions Announces First Quarter Fiscal Year 2004 Results.
Next Article:IMPAX Signs Agreement with Andrx and Teva for Generic Formulations of Wellbutrin SR and Zyban.



Related Articles
New Appointments Add Depth to Signature Board and Management.
Weatherhead School of Management Announces Bioscience Entrepreneurship MBA Specialization.
Neuro Bioscience Inc. Appoints Edward W. Kelly as President and Chief Executive Officer and Donald G. Anderson as Chief Operating Officer.
Neuro Bioscience Inc. Appoints Edward W. Kelly as President and Chief Executive Officer and Donald G. Anderson as Chief Operating Officer.
Stratos and Battelle Defense Systems Group Collaborate on Product Co-Development and Joint Marketing Efforts; World Class R&D Organization To Partner...
PURE Bioscience Announces Sale of Water Treatment Division and Trust Deed Asset, Resulting in Proceeds Exceeding $4.3 Million.
PURE Bioscience Signs Definitive Agreement for Sale of Water Treatment Division; Company to Receive $4.75 Million by December 5, 2003.
Lumera Announces New Heads of Bioscience And Electro-Optics Divisions; Promotion of Lumera Veterans Places Increased Focus on Roll-out of Commercial...
Two Colorado Bioscience Legislative Initiatives Rank Among BIO's Best Practices in the Nation.
Lumera Announces New Podcast Interview with Dr. Joseph Vallner; Next in 2007 Lumera Experts Series.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles